A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 1,124,281 shares of ABBV stock, worth $197 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
1,124,281
Previous 1,092,152 2.94%
Holding current value
$197 Million
Previous $187 Million 18.52%
% of portfolio
0.3%
Previous 0.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $5.26 Million - $6.4 Million
32,129 Added 2.94%
1,124,281 $222 Million
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $560,649 - $654,712
-3,622 Reduced 0.33%
1,092,152 $187 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $2.95 Million - $3.36 Million
18,438 Added 1.71%
1,095,774 $200 Million
Q4 2023

Jan 16, 2024

BUY
$137.6 - $154.97 $3.46 Million - $3.9 Million
25,135 Added 2.39%
1,077,336 $167 Million
Q3 2023

Oct 24, 2023

SELL
$133.59 - $154.65 $4.31 Million - $4.98 Million
-32,227 Reduced 2.97%
1,052,201 $157 Million
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $3.41 Million - $4.24 Million
25,706 Added 2.43%
1,084,428 $146 Million
Q1 2023

Apr 14, 2023

SELL
$144.61 - $166.54 $22.5 Million - $26 Million
-155,853 Reduced 12.83%
1,058,722 $169 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $4.2 Million - $5.04 Million
-30,367 Reduced 2.44%
1,214,575 $196 Million
Q3 2022

Oct 25, 2022

BUY
$134.21 - $153.93 $3.79 Million - $4.34 Million
28,212 Added 2.32%
1,244,942 $167 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $13.8 Million - $17.5 Million
-100,256 Reduced 7.61%
1,216,730 $186 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $8.73 Million - $10.8 Million
66,167 Added 5.29%
1,316,986 $213 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $3.08 Million - $3.9 Million
28,703 Added 2.35%
1,250,819 $169 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $2.09 Million - $2.37 Million
19,631 Added 1.63%
1,222,116 $132 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $4.97 Million - $5.54 Million
47,254 Added 4.09%
1,202,485 $135 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $9.69 Million - $10.7 Million
94,674 Added 8.93%
1,155,231 $125 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $10.8 Million - $14.5 Million
133,760 Added 14.43%
1,060,557 $114 Million
Q3 2020

Nov 04, 2020

BUY
$85.91 - $100.83 $2.1 Million - $2.47 Million
24,500 Added 2.72%
926,797 $81.2 Million
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $6.12 Million - $8.18 Million
83,348 Added 10.18%
902,297 $88.6 Million
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $3.34 Million - $5.07 Million
51,823 Added 6.76%
818,949 $62.4 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $6.32 Million - $7.91 Million
87,611 Added 12.89%
767,126 $67.9 Million
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $6.49 Million - $7.8 Million
-103,021 Reduced 13.17%
679,515 $51.5 Million
Q2 2019

Aug 06, 2019

SELL
$65.7 - $83.98 $56.4 Million - $72.1 Million
-858,664 Reduced 52.32%
782,536 $56.9 Million
Q1 2019

May 06, 2019

BUY
$77.14 - $90.79 $12.9 Million - $15.2 Million
167,199 Added 11.34%
1,641,200 $132 Million
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $11.1 Million - $13.7 Million
143,209 Added 10.76%
1,474,001 $136 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $3.1 Million - $3.45 Million
34,901 Added 2.69%
1,330,792 $126 Million
Q2 2018

Jul 30, 2018

BUY
$89.78 - $106.23 $6.91 Million - $8.18 Million
76,962 Added 6.31%
1,295,891 $120 Million
Q1 2018

Apr 16, 2018

BUY
$92.01 - $123.21 $4.35 Million - $5.82 Million
47,277 Added 4.04%
1,218,929 $115 Million
Q4 2017

Feb 09, 2018

BUY
$89.56 - $98.21 $4.11 Million - $4.51 Million
45,920 Added 4.08%
1,171,652 $113 Million
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $1.89 Million - $2.42 Million
27,106 Added 2.47%
1,125,732 $100 Million
Q2 2017

Aug 15, 2017

BUY
N/A
1,098,626
1,098,626 $79.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.